Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the August issue of the Archives, Keen et al1 discuss recent clinical evidence that UV-seeking behavior should perhaps be seen as an addictive disorder.2 - 3 This insight is important because it implies that excessive tanning behavior should be approached as a form of substance abuse and that altering patients' sunning habits will not be a trivial matter. Unfortunately, Keen et al do not mention recent molecular and clinical data supporting the idea that excessive UV tanning behavior results from an addiction to endogenous opioids.4 - 5 I believe that these recent data strongly justify treating excessive sun-seeking behavior as an addiction. This idea has important implications for dermatologic practice, and the recent report describing its possible molecular background4 may have escaped most readers' attention.
Induction of pigmentation by UV irradiation requires keratinocytes to secrete α-melanocyte-stimulating hormone (α-MSH), a cleavage product of the prohormone peptide pro-opiomelanocortin (POMC). In 2007, Cui et al4 elegantly demonstrated that the tumor suppressor protein p53, which is stabilized on detection of DNA damage, induces POMC production in keratinocytes. Besides α-MSH, POMC cleavage yields β-endorphin, an endogenous opioid that can induce, among other effects, analgesia and euphoria. This fascinating mechanism might have evolved to provide analgesia for sunburns related to accidental overexposure to UV radiation, but one might equally and perhaps more plausibly interpret it as a reward system that makes the organism seek sun exposure to, for example, ensure adequate vitamin D production. One might wonder what has selected for DNA damage, rather than some form of light or UV sensing, as a trigger for pigmentation.
Regardless, in our present society, with sun exposure so easy to come by, the mechanism may no longer be adaptive. In my view, it can certainly help to explain why sunning can be addictive. Naloxone has been shown to induce withdrawal symptoms in regular sunbathers.5 This observation further supports the notion that endogenous opioids are involved in tanning behavior.
In conclusion, recent molecular biological findings lend support to the idea that excessive sunbathing should be seen as an addiction. These findings also suggest that excessive sunbathers should be treated as addicts and that simple advice from a physician to avoid excessive sun exposure will probably not alter their behavior.
Corresponding Author: Dr Van Steensel, Department of Dermatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, the Netherlands (m.vansteensel@mumc.nl).
Financial Disclosure: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Addiction
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.